Trials / Active Not Recruiting
Active Not RecruitingNCT04317794
Observational, Postmarketing Surveillance Study of Spinraza Injection (Nusinersen Sodium)
A Multicenter, Observational, Postmarketing Surveillance Study of Spinraza Injection (Nusinersen Sodium) When Used in Routine Medical Practice in Korea
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 74 (actual)
- Sponsor
- Biogen · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The primary objective is to evaluate the safety of nusinersen sodium injection in the postmarketing setting in Korea. The secondary objective is to evaluate the effectiveness of nusinersen sodium injection in the postmarketing setting in Korea.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Nusinersen Sodium Injection | Administered as specified in the treatment arm. |
Timeline
- Start date
- 2019-07-02
- Primary completion
- 2027-02-05
- Completion
- 2027-02-05
- First posted
- 2020-03-23
- Last updated
- 2025-07-17
Locations
16 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04317794. Inclusion in this directory is not an endorsement.